Navigation Links
New Sub-Analysis of RE-LY Trial Examines Pradaxa in Patients with Atrial Fibrillation Undergoing Cardioversion
Date:1/5/2011

for human and veterinary medicine.

In 2009, Boehringer Ingelheim posted net sales of US $17.7 billion (12.7 billion euro) while spending 21% of net sales in its largest business segment, Prescription Medicines, on research and development.

For more information, please visit http://us.boehringer-ingelheim.com and follow us on Twitter at http://twitter.com/boehringerus.

*Although studied in the RE-LY trial, dabigatran etexilate 110mg is not approved for use

(1)  Nagarakanti R, et al. "Dabigatran versus Warfarin in Patients with Atrial Fibrillation: An Analysis of Patients Undergoing Cardioversion. Circulation. 2011;123:131-136.

(2) PRADAXA prescribing information

(3) Connolly SJ, et al. "Dabigatran versus Warfarin in Patients with Atrial Fibrillation." New England Journal of Medicine. 2009; 361:1139-51.

(4) Ezekowitz MD, et al. "Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulation therapy, warfarin, compared with dabigatran." American Heart Journal.  2009; 157: 805-810.

(5) Oldgren J, et al. "Dabigatran Versus Warfarin In Atrial Fibrillation Patients With Low, Moderate And High Chads2 Score - A Re-ly Subgroup Analysis." Presented at AHA, 2009.

(6) NHLBI website. "What is AFib?" Available at: http://www.nhlbi.nih.gov/health/dci/Diseases/af/af_what.html. Accessed on: August 2, 2010.

(7) Go, Alan S., and Elaine M. Hylek et al. Prevalence of Diagnosed Atrial Fibrillation in Adults: National Implications for Rhythm Management and Stroke Prevention: the ATRIA Study. JAMA. 2002; 285:2370-2375.

(8) Fuster, V et al. "Atrial Fibrillation: Developed in Collaboration With the European Heart Committee to Revise the 2001 Guidelines for the Management of Patients With the European Society of Cardiolog
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. New PLATO Sub-Analysis of CABG Patients Presented at ACC
2. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
3. Data Published in The Lancet Compare Dabigatran Etexilate to Dose-Adjusted Warfarin Across RE-LY® Trial Centers
4. New Analyses of Data From RE-LY Trial, Involving Oral Anticoagulant Pradaxa, to be Presented at American Heart Associations Scientific Sessions
5. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
8. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
9. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... and ASPEN, Colo. , April ... with the Chris Klug Foundation (CKF), is pleased to sponsor ... being accepted for the award, which will recognize two ... life, whether it is a career accomplishment, participation in ... life with family and loved ones. ...
(Date:4/1/2015)... , April 1, 2015 According ... (Neuro & Spine Surgery, Plastic and Reconstructive Surgery, Oncology, ... (Hospitals, Outpatient Facilities) - Global Forecast to 2020", published ... reach $806.6 Million by 2020 from $402.2 Million in ... 2020.. Browse   7 6 ...
(Date:4/1/2015)... INDIANAPOLIS , April 1, 2015 Eli Lilly ... results for the first quarter of 2015 on Thursday, April ... that day with the investment community and media to further ... will begin at 9:00 a.m. EDT. Investors, media, and the ... call through a link that will be posted on Lilly,s ...
Breaking Medicine Technology:Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients 2Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients 3Surgical Microscopes Market Worth $806.6 Million by 2020 2Surgical Microscopes Market Worth $806.6 Million by 2020 3Surgical Microscopes Market Worth $806.6 Million by 2020 4Lilly Confirms Date and Conference Call for First-Quarter 2015 Financial Results Announcement 2
... the launch of its new depot service for Agilent ... to BioSurplus for repair and preventative maintenance by trained ... major cost savings to customers outside of biotech hubs ... An introductory 15% discount on preventative maintenance services ...
... 8, 2012  Insmed Incorporated (Nasdaq: INSM ), a ... March 31, 2012. Key Recent Highlights: ... hold on ARIKACE® (liposomal amikacin for inhalation) in Cystic Fibrosis ... Initiated dosing in CL inical E valuation of ...
Cached Medicine Technology:BioSurplus Announces Launch of Depot Service for Agilent and AKTA HPLCs 2Insmed Announces First Quarter 2012 Financial Results 2Insmed Announces First Quarter 2012 Financial Results 3Insmed Announces First Quarter 2012 Financial Results 4Insmed Announces First Quarter 2012 Financial Results 5Insmed Announces First Quarter 2012 Financial Results 6Insmed Announces First Quarter 2012 Financial Results 7
(Date:4/1/2015)... 01, 2015 GrassrootsHealth, an international ... continuing medical education (CME) courses about vitamin ... become more confident in measuring, prescribing, and tracking ... of these CME courses, practitioners can apply for ... courses available are “Vitamin D, Sunshine, Optimal Health: ...
(Date:4/1/2015)... 2015 Tempaper has joined forces with ... giving campaign that will raise critical funds to help ... disease across the United States. , Throughout the month ... Tempaperdesigns.com will automatically receive free domestic ground shipping ... urgently needed progress to children and adults affected by ...
(Date:4/1/2015)... April 01, 2015 Like a mosaic ... the scientific understanding of the potential causes of rosacea. ... the National Rosacea Society (NRS) to educate the public ... facial disorder now estimated to affect more than 16 ... medical research on rosacea through its patient-funded research grants ...
(Date:4/1/2015)... 2015 IQ Formulations , one of ... supplement companies in the U.S., today is commending GNC for ... control standards for its herbal supplements.* GNC vowed that its ... ensure the accuracy of labeling on its products. , ... IQ Formulations CEO Jay Cohen said: , “In ...
(Date:4/1/2015)... 01, 2015 Health Advocate™, Inc., the ... subsidiary of West Corporation, today launched its new Health ... and through the Health Advocate member website, features ... and stay, healthy. , “We’re pleased to introduce this ... public,” said Martin Rosen, Executive Vice President, Health Advocate. ...
Breaking Medicine News(10 mins):Health News:GrassrootsHealth Launches CME Courses about Vitamin D 2Health News:GrassrootsHealth Launches CME Courses about Vitamin D 3Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 2Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 2Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 4Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 5Health News:IQ Formulations Applauds GNC for Enhancing Its Testing and Quality Control Processes for Herbal Supplements 2Health News:Health Advocate Launches New Health and Wellness Blog 2
... Experts cautious about validity, usefulness of some on the market ... 40-year-old head of the White House Office of Management and ... iced, that he took a genetic test to see if ... According to the results, his body is perfectly suited to ...
... do you gift wrap a goat? Or a cow, a pig, or ... in the World," you don,t have to. All you need to do ... out the order form and mail it back. , Soon, your ... in need, minus the tape, ribbons and bows, and it will be ...
... ... hospital in Mississippi has more Five-Star Ratings than Baptist Medical Center ... ratings organization. Baptist is among the top 10 percent in the ... a comprehensive annual study released today by HealthGrades. Baptist achieved five ...
... ... for Managers) to be held at Sheraton, Wakefield, MA, , ... Boston, MA (PRWEB) October 14, 2009 -- ... program, ,Strategic Problem Solving & Advanced Time Management, to be held Wednesday, November 18th ...
... 13 The following is a statement from Mark ... regarding the Senate Finance Committee vote today on the ... be cautiously optimistic that an economically sustainable health care reform ... an important step toward ensuring long-term health care security and ...
... Finance Committee,s approval of an ambitious health reform plan marks ... care to tens of millions of people who lack it, ... face exorbitant charges, and begin to address the nation,s most ... costs. , The Congressional Budget Office has reported that the ...
Cached Medicine News:Health News:Are Commercial Genetic Tests Worth Taking? 2Health News:Are Commercial Genetic Tests Worth Taking? 3Health News:Better Than a Sweater for Christmas 2Health News:Baptist Medical Center's Patient Outcomes Among Highest in the Nation, According to Independent Study 2Health News:Baptist Medical Center's Patient Outcomes Among Highest in the Nation, According to Independent Study 3Health News:Baptist Medical Center's Patient Outcomes Among Highest in the Nation, According to Independent Study 4Health News:One Day Management Training Program to be Offered November 18 in Boston Area 2Health News:One Day Management Training Program to be Offered November 18 in Boston Area 3Health News:One Day Management Training Program to be Offered November 18 in Boston Area 4Health News:One Day Management Training Program to be Offered November 18 in Boston Area 5Health News:Statement of Robert Greenstein, Executive Director, Center on Budget and Policy Priorities, on The Senate Finance Committee's Health Reform Plan 2Health News:Statement of Robert Greenstein, Executive Director, Center on Budget and Policy Priorities, on The Senate Finance Committee's Health Reform Plan 3
Tempting and mesmerizing Jaguar features a narrow black slit surrounded by reflective metallic teal....
Soft silicone brush tip allows atraumatic brushing and manipulation of retina surface. Silicone brush extends 3mm beyond end of cannula. Luer lock hub for easy, secure connection to a backflush handl...
Medpor Sphere Inserter. The Inserter is provided as a value added item to Medpor Orbital Implants....
Healon vitreous aspirating cannula, 21 gauge....
Medicine Products: